End of Phase II Meeting definition

End of Phase II Meeting. End of Phase II Meeting means that certain end of phase II meeting between Adamas and the FDA with respect to Adamas’ IND for the Memantine-Donepezil FDC Product[*].
Sample 1Sample 2
End of Phase II Meeting means a meeting with a Regulatory Authority in which AbbVie’s plan to commence a Phase III that would be the subject of a Drug Approval Application for a First Licensed Product are reviewed.
Sample 1Sample 2Sample 3
End of Phase II Meeting means the meeting with Acologix and the FDA to review the data and results of any Phase II Trials conducted for a Product, and to discuss with the FDA Acologix’ plan to commence further clinical Development of such Product with the intent of achieving Regulatory Approval thereafter.
Sample 1Sample 2

Examples of End of Phase II Meeting in a sentence

  • Records of these interactions can be found in an End of Phase II Advice letter issued December 8, 2009, End of Phase II Meeting Minutes issued June 3, 2010, Written Responses to proposed analyses issued May 22, 2012 and pre-NDA Meeting Minutes issued December 17, 2012.

  • Rural and coastal communities both show high levels of entrepreneurial small businesses and the success of these is critical to development in these areas.

  • Exhibit III Trials Conducted for PH-HFpEF4 Milestones Enroll First Patient March 2019 Full Enrollment 1Q:20Last Patient, Last Visit April 2020 Topline data 2Q:20Presentation of data at conference Fall 2020 End of Phase II Meeting with FDA 2H:20 Launch Phase III 2021Summary Now that the HELP trial has completed the last visit for the last patient, management has guided toward a late second quarter 2020 topline readout.

  • It has completed the End of Phase II Meeting in US Food and Drug Administration (FDA), and approved by China CFDA to carry out phase III clinical trial in several centers in Asia.


More Definitions of End of Phase II Meeting

End of Phase II Meeting is a positive End of Phase II meeting with the FDA on the bavituximab second-line NSCLC program (defined as moving into Phase III design); and evidence of the same in form and content reasonably acceptable to the Lenders.
Sample 1
End of Phase II Meeting means Teva’s meeting with the FDA consistent with 21 C.F.R. Section 312.47(b)(1).
Sample 1
End of Phase II Meeting has the meaning set forth in Section 6.7(e).
Sample 1

Related to End of Phase II Meeting

  • Scoping meeting means a meeting between representatives of the applicant and the EDU conducted for but not limited to the following purposes:

  • Review Meeting means a meeting to be held in accordance with clause B19 (Review Meetings) or as otherwise requested in accordance with clause B19.2 (Review Meetings)

  • Court Meeting means the meeting(s) of the Scheme Shareholders to be convened by order of the Court pursuant to section 896 of the Companies Act, notice of which will be set out in the Scheme Document, for the purpose of approving the Scheme, including any adjournment thereof;

  • JMC has the meaning set forth in Section 3.01.

  • Open meeting or "public meeting" means a meeting at which the public may be present.

  • JRC has the meaning set forth in Section 2.1.1.

  • ordinary meeting means a meeting held by determination of the Board (SER r.115(1)).

  • JSC has the meaning set forth in Section 3.1.

  • Board Meeting means a meeting of the Board;

  • JDC has the meaning set forth in Section 3.2.

  • Company Meeting means the special meeting of Company Shareholders, including any adjournment or postponement of such special meeting in accordance with the terms of the Arrangement Agreement, to be called and held in accordance with the Interim Order to consider the Arrangement Resolution.

  • Public meeting means a meeting that is required to be open to the public under Title 52, Chapter 4, Open and Public Meetings Act.

  • General Meeting means the annual or any special general meeting of the Association.

  • Virtual Meeting means any general meeting of the Shareholders (or any meeting of the holders of any Class of Shares) at which the Shareholders (and any other permitted participants of such meeting, including without limitation the chairman of the meeting and any Directors) are permitted to attend and participate solely by means of Communication Facilities.

  • Phase II Study means a human clinical trial, for which the primary endpoints include a determination of dose ranges and/or a preliminary determination of efficacy in patients being studied as described in 21 C.F.R. § 312.21(b) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • hybrid meeting means a general meeting convened for the (i) physical attendance by shareholders and/or proxies at the Principal Meeting Place and where applicable, one or more Meeting Locations and (ii) virtual attendance and participation by shareholders and/or proxies by means of electronic facilities;

  • Shareholders Meeting shall have the meaning set forth in Section 5.1.

  • Bondholders’ Meeting means a meeting among the Bondholders held in accordance with Clause 17 (Bondholders’ Meeting).

  • Steering Committee has the meaning set forth in Section 2.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • meeting of shareholders means an annual meeting of shareholders or a special meeting of shareholders;

  • JCC has the meaning set forth in Section 2.1.

  • Committee Meeting means a meeting of the Committee.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Pre-bid Meeting means Pre-bid meeting to be held as per the schedule indicated in the Schedule for the Tender hereof;